TACE联合3D-CRT控制原发性肝癌1例并文献复习

发布时间：2018-06-13 10:11

本文选题：TACE + 3D-CRT　；参考：《浙江大学》2016年硕士论文

【摘要】：目的：探讨TACE联合3D-CRT在原发性肝癌治疗中的价值。方法：收集自2011年-2015年期间在浙江萧山医院肿瘤综合科行TACE联合3D-CRT治疗并获得无瘤生存36个月以上的中晚期原发性肝癌患者(1例)的临床及影像学资料。以案例分析的形式汇报该患者的整体治疗过程,最后通过文献复习,研究TACE联合3D-CRT在原发性肝癌中的治疗价值。结果：该患者经过以TACE为基础联合3D-CRT体外放疗及BSD-2000深部热疗的方案综合治疗,安全有效地控制了疾病进展。截止目前无瘤生存超过60个月未见复发或远处转移,一般状况良好。结论：TACE是治疗无法手术中晚期原发性肝癌患者的常用手段；以TACE为基础联合3D-CRT体外放疗及BSD-2000深部热疗治疗中晚期原发性肝癌是安全有效的。
[Abstract]:Objective: to evaluate the value of TACE combined with 3 D-CRT in the treatment of primary liver cancer. Methods: from 2011 to 2015, the clinical and imaging data of 1 patient with advanced hepatocellular carcinoma (HCC) who were treated with TACE combined with 3D-CRT in Department of Oncology, Xiaoshan Hospital, Zhejiang Province from 2011 to 2015 were collected. The whole treatment process of the patient was reported in the form of case analysis. Finally, the value of TACE combined with 3D-CRT in the treatment of primary liver cancer was studied through literature review. Results: after TACE combined with 3D-CRT in vitro radiotherapy and BSD-2000 deep hyperthermia, the disease progression was controlled safely and effectively. No recurrence or distant metastasis has been seen for more than 60 months and is generally in good condition. ConclusionThree TACE is a common method for the treatment of advanced primary liver cancer, and TACE combined with 3D-CRT in vitro radiotherapy and BSD-2000 deep hyperthermia is a safe and effective method for the treatment of advanced primary liver cancer.
【学位授予单位】：浙江大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R735.7

【参考文献】